GlassScriptPhysician profile
Casey R Bowles
NPI 1962885020
$3,158.57
in general payments reported to CMS, 2019-2025
31 companies · $1,578 in 2025
The $1,578 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $30.21 · 2023: $193 · 2024: $218 · 2025: $1,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,047 · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,047.01 |
| Food and Beverage | $941.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,447.02 | 2024-2025 | 3m Cavilon, Kerramax Care, 3m Coban |
| Novo Nordisk INC | $303.03 | 2021-2024 | Wegovy |
| Next Science LLC | $177.71 | 2023 | Surgx, Blastx, Xperience |
| Lilly USA, LLC | $135.81 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $122.77 | 2021 | |
| Abbvie INC. | $114.82 | 2021 | |
| Amarin Pharma, INC. | $79.51 | 2021 | |
| Amgen INC. | $78.58 | 2021 | |
| Kerecis Limited | $73.32 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Janssen Pharmaceuticals, INC | $70.24 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $70.07 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.66 | 2021 | |
| Smith+Nephew, INC. | $45.76 | 2022-2025 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $44.28 | 2021 | |
| Convatec INC. | $36.11 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $30.81 | 2025 | |
| Esperion Therapeutics, INC. | $29.08 | 2021 | |
| Cashflow Solutions, LLC | $26.97 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Sanofi-Aventis U.S. LLC | $24.44 | 2021 | |
| Organogenesis INC. | $23.36 | 2024 | Apligraf |
| Stimlabs LLC | $20.41 | 2025 | Geistlich Derma-Gide |
| Advanced Oxygen Therapy INC. | $15.68 | 2025 | Topical Oxygen Chamber For Extremities |
| Horizon Therapeutics Plc | $15.65 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.26 | 2021 | |
| Eisai INC. | $15.22 | 2021 | |
| Kci USA, INC. | $15.07 | 2021 | |
| Urgo Medical North America, LLC | $14.79 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.60 | 2021 | |
| Hartmann USA, INC. | $13.93 | 2024 | Zetuvit Plus 10x10 P10 |
| Genentech USA, INC. | $12.83 | 2021 | |
| Pfizer INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Bowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.